Tenax Therapeutics, Inc.
TENX
$1.80
-$0.03-1.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.03% | -139.18% | -198.82% | -197.55% | -150.42% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.21% | 245.90% | 1,569.25% | 6,908.68% | 3,905.35% |
| Change in Net Operating Assets | 18.76% | -21.76% | -243.88% | 10.34% | 118.29% |
| Cash from Operations | -131.95% | -129.61% | -141.71% | -107.98% | -73.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 50.84% |
| Issuance of Common Stock | 2,287.56% | 1,990.62% | 736.87% | 101.70% | 245,100.00% |
| Repurchase of Common Stock | -- | -- | -- | 87.61% | 87.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -76.85% | -77.77% | 413.70% |
| Cash from Financing | -49.50% | -60.65% | -61.44% | -72.93% | 1,457.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.98% | -92.61% | -96.81% | -98.79% | 2,496.02% |